医学理论与实践
醫學理論與實踐
의학이론여실천
The Journal of Medical Theory and Practice
2014年
20期
2672-2673,2679
,共3页
丛智荣%徐小红%曹永峰%倪静怡%宋诸臣
叢智榮%徐小紅%曹永峰%倪靜怡%宋諸臣
총지영%서소홍%조영봉%예정이%송제신
非霍奇金淋巴瘤%血清神经元特异性烯醇化酶%CA125抗原%β2微球蛋白%预后
非霍奇金淋巴瘤%血清神經元特異性烯醇化酶%CA125抗原%β2微毬蛋白%預後
비곽기금림파류%혈청신경원특이성희순화매%CA125항원%β2미구단백%예후
Non-Hodgkin lymphoma%NSE%CA125%β2-MG%Prognosis
目的:探讨NHL患者血清NSE、CA125及β2-MG水平对判断临床疗效和预后的价值。方法:测定46例NHL患者化疗前、后血清NSE、CA125及β2-MG ,分析其与临床疗效和3年生存率的相关性。结果:(1)血清NSE增高患者化疗有效率、3年生存率低于血清 NSE正常患者,差异有统计学意义(P<0.05);其中化疗有效患者化疗后血清NSE水平较化疗前明显降低,差异有统计学意义(P<0.05)。(2)血清CA125增高患者化疗有效率、3年生存率低于血清CA125正常患者,差异有统计学意义(P<0.05);化疗有效患者化疗后血清CA125水平较化疗前明显降低,差异有统计学意义(P<0.05)。(3)血清β2-MG增高患者化疗有效率低于血清β2-MG正常患者,差异有统计学意义(P<0.05);血清β2-MG增高患者与正常患者3年生存率比较,差异无统计学意义(P>0.05);化疗有效患者化疗后血清β2-MG水平较化疗前明显降低,差异有统计学意义(P<0.05)。结论:NHL患者血清NSE、CA125及β2-MG水平与化疗敏感性及临床预后密切相关,对判断疗效和预后有重要价值。
目的:探討NHL患者血清NSE、CA125及β2-MG水平對判斷臨床療效和預後的價值。方法:測定46例NHL患者化療前、後血清NSE、CA125及β2-MG ,分析其與臨床療效和3年生存率的相關性。結果:(1)血清NSE增高患者化療有效率、3年生存率低于血清 NSE正常患者,差異有統計學意義(P<0.05);其中化療有效患者化療後血清NSE水平較化療前明顯降低,差異有統計學意義(P<0.05)。(2)血清CA125增高患者化療有效率、3年生存率低于血清CA125正常患者,差異有統計學意義(P<0.05);化療有效患者化療後血清CA125水平較化療前明顯降低,差異有統計學意義(P<0.05)。(3)血清β2-MG增高患者化療有效率低于血清β2-MG正常患者,差異有統計學意義(P<0.05);血清β2-MG增高患者與正常患者3年生存率比較,差異無統計學意義(P>0.05);化療有效患者化療後血清β2-MG水平較化療前明顯降低,差異有統計學意義(P<0.05)。結論:NHL患者血清NSE、CA125及β2-MG水平與化療敏感性及臨床預後密切相關,對判斷療效和預後有重要價值。
목적:탐토NHL환자혈청NSE、CA125급β2-MG수평대판단림상료효화예후적개치。방법:측정46례NHL환자화료전、후혈청NSE、CA125급β2-MG ,분석기여림상료효화3년생존솔적상관성。결과:(1)혈청NSE증고환자화료유효솔、3년생존솔저우혈청 NSE정상환자,차이유통계학의의(P<0.05);기중화료유효환자화료후혈청NSE수평교화료전명현강저,차이유통계학의의(P<0.05)。(2)혈청CA125증고환자화료유효솔、3년생존솔저우혈청CA125정상환자,차이유통계학의의(P<0.05);화료유효환자화료후혈청CA125수평교화료전명현강저,차이유통계학의의(P<0.05)。(3)혈청β2-MG증고환자화료유효솔저우혈청β2-MG정상환자,차이유통계학의의(P<0.05);혈청β2-MG증고환자여정상환자3년생존솔비교,차이무통계학의의(P>0.05);화료유효환자화료후혈청β2-MG수평교화료전명현강저,차이유통계학의의(P<0.05)。결론:NHL환자혈청NSE、CA125급β2-MG수평여화료민감성급림상예후밀절상관,대판단료효화예후유중요개치。
To research the values of NSE ,CA125 andβ2-MG for judgement of effect and prognosis in non-Hodgkin lymphoma .Methods:The data of 46 patients with NHL were retrospectively analysed ,the relationships be-tween NSE ,CA125 andβ2-MG activities and the effect of treatment as well as prognosis were studied .Results:(1)The chemotherapy efficacy and three-year survival rate of patients with increased NSE were signifecantly lower than that of patients with normal NSE(P<0 .05);the NSE level of patients with positive response was signifecantly lower than that of patients with negative response in group with increased NSE (P<0 .05) .(2)The chemotherapy efficacy and three-year survival rate of patients with increased CA125 were signifecantly lower than that of patients with normal CA125 (P<0 .05);the CA125 level of patients with positive response was signifecantly lower than that of patients with nega-tive response in group with increased CA125(P<0 .05) .(3)The chemotherapy efficacy of patients with increased β2-MG were signifecantly lower than that of patients with normalβ2-MG (P<0 .05);there was no difference in three-year survival rate between patients with increasedβ2-MG and patients with normalβ2-MG ;theβ2-MG level of patients with positive response was signifecantly lower than that of patients with negative response in group with increasedβ2-MG (P<0 .05) .Conclusion:The levels of NSE ,CA125 andβ2-MG are useful for the judgment of severity ,response to treat-ment and prognosis of NHL .